William Blair Downgrades Neogenomics (NEO) to Market Perform
Tweet Send to a Friend
(Updated - July 29, 2025 1:00 PM EDT)
William Blair analyst Andrew Brackmann downgraded Neogenomics (NASDAQ: NEO) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
William Blair analyst Andrew Brackmann downgraded Neogenomics (NASDAQ: NEO) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
